BackGW Pharmaceuticals Overview

GW Pharmaceuticals Inventory

Track GW Pharmaceuticals's inventory ($140M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$137.63M
↑ 54.54% YoYΔ $48.57M vs prior year quarter

Peer average

Loading

GW Pharmaceuticals Inventory History

Loading

GW Pharmaceuticals vs. peers: Inventory Comparison

Loading

GW Pharmaceuticals Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GW Pharmaceuticals (GWPH) FAQ

As of the most recent data (March 2021), GWPH shows a inventory of $140M. That compares with $89M in the prior-year period — up 54.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GWPH's inventory is now $140M (was $89M) — a 54.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether GW Pharmaceuticals is outperforming or lagging.

Tracking GWPH's inventory over time shows whether GW Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $140M That compares with $89M in the prior-year period — up 54.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has GW Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $140M) with ownership activity and broader fundamentals.

GW Pharmaceuticals's inventory is $140M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.